Outcomes of permanent pacemakers and implantable cardioverter-defibrillators in an adult congenital heart disease population

Background: Brady- and tachyarrhythmias commonly complicate adult congenital heart disease (ACHD). Permanent pacemakers (PPMs) or implantable cardioverter–defibrillators (ICDs) are often utilised to prevent morbidity or mortality related to arrhythmia, but can also be associated with significant mor...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	International Journal of Cardiology Congenital Heart Disease
المؤلفون الرئيسيون:	Jason Chami, Benjamin M. Moore, Calum Nicholson, Rachael Cordina, David Baker, David S. Celermajer
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-03-01
الموضوعات:	Adult congenital heart disease Arrhythmia Implantable devices Pacemakers Implantable cardioverter-defibrillators
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2666668523000526

مواد مشابهة

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
حسب: Takeshi Nakae, MD, وآخرون
منشور في: (2010-01-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
حسب: Konstantinos Kossidas, MD, FHRS, وآخرون
منشور في: (2017-12-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
حسب: Ryoji Kishi, MD, وآخرون
منشور في: (2005-01-01)

Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants
حسب: Javad Shahabi, وآخرون
منشور في: (2024-08-01)

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
حسب: Javad Shahabi, وآخرون
منشور في: (2023-01-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
حسب: Nikolaos A Papakonstantinou, وآخرون
منشور في: (2020-01-01)

Stepwise cardiac rehabilitation adjustment after exercise-induced implantable cardioverter defibrillator shock: a case report
حسب: Hidetoshi Yanagi, وآخرون
منشور في: (2025-04-01)

Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study
حسب: Hui‐Qiang Wei, وآخرون
منشور في: (2025-04-01)

Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible
حسب: Matanyahu Rubinstein, وآخرون
منشور في: (2023-07-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
حسب: Raza M. Alvi, وآخرون
منشور في: (2018-09-01)

Current status of wearable cardioverter‐defibrillator use in Japan
حسب: Reina Tonegawa‐Kuji, وآخرون
منشور في: (2024-08-01)

The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
حسب: Özge Çakmak Karaaslan, وآخرون
منشور في: (2023-01-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
حسب: Paola Ferrari, MD, وآخرون
منشور في: (2016-06-01)

Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators
حسب: Anna Giulia Pavon, وآخرون
منشور في: (2022-01-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
حسب: Boldizsar Kovacs, وآخرون
منشور في: (2019-11-01)

Mycobacterium fortuitum causing infection of a biventricular pacemaker/implantable cardioverter defibrillator
حسب: Yuhning L Hu, وآخرون
منشور في: (2012-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
حسب: Mehmet K. Aktas, MD, MBA, FHRS, وآخرون
منشور في: (2020-06-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
حسب: Temirkhan Begisbayev, وآخرون
منشور في: (2022-05-01)

Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
حسب: Amarapalli Jayachandra, وآخرون
منشور في: (2024-08-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
حسب: Bayda'a A. Kareem
منشور في: (2014-04-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
حسب: Ufuk Eryılmaz, وآخرون
منشور في: (2013-10-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
حسب: Andrew M. Leong, وآخرون
منشور في: (2024-03-01)

Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study
حسب: Safi Morteza, وآخرون
منشور في: (2017-09-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
حسب: Janet K. Han, وآخرون
منشور في: (2022-02-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
حسب: Hirota Kida, وآخرون
منشور في: (2025-06-01)

“Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database
حسب: Diogo de Almeida Fernandes, وآخرون
منشور في: (2023-12-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for 2022
حسب: V. Traykov, وآخرون
منشور في: (2023-12-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
حسب: Iwanari Kawamura, وآخرون
منشور في: (2019-12-01)

Subcutaneous cardioverter-defibrillator implantation in an adult with congenital heart disease and left infra-mammary pacemaker
حسب: Soham Dasgupta, وآخرون
منشور في: (2024-03-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
حسب: Boldizsar Kovacs, وآخرون
منشور في: (2020-09-01)

Multiple Implantable Cardioverter-Defibrillator Shocks in Ischemic Cardiomyopathy Compels Coronary Vascularization Reassessment
حسب: Guşetu Gabriel, وآخرون
منشور في: (2023-12-01)

Arrhythmia Risk During the 2016 US Presidential Election: The Cost of Stressful Politics
حسب: Lindsey Rosman, وآخرون
منشور في: (2021-06-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
حسب: Vineetha Kanneganti, وآخرون
منشور في: (2024-03-01)

Dosimetric feasibility of stereotactic arrhythmia radioablation for ventricular tachycardia in patients with a subcutaneous implantable cardioverter defibrillator
حسب: Lena Kaestner, وآخرون
منشور في: (2025-07-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
حسب: Christos Zormpas, وآخرون
منشور في: (2021-04-01)

Patients’ Knowledge about Safe Measures Post Implantable Cardioverter Defibrillator
حسب: Mohammed Kadhum Sadaq, وآخرون
منشور في: (2025-09-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
حسب: Jose Maria Frutos Perez, وآخرون
منشور في: (2021-03-01)

Adaptation status and related factors in patients living with implantable cardioverter defibrillators
حسب: Mohammadreza Razavi, وآخرون
منشور في: (2022-01-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
حسب: Yuki Konno, وآخرون
منشور في: (2025-04-01)

Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
حسب: Christian Hauck, وآخرون
منشور في: (2022-11-01)